Exicure, Inc.
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
Last updated:
Abstract:
Liposomal spherical nucleic acids that function as multivalent immune modulators are provided according to the invention. The liposomal spherical nucleic acids of the invention are useful prophylactic and therapeutic applications as well as research and diagnostic indications.
Status:
Grant
Type:
Utility
Filling date:
4 Jun 2015
Issue date:
8 Oct 2019